Illumine Investment Management LLC Invests $825,000 in JPMorgan Chase & Co. (NYSE:JPM)

Illumine Investment Management LLC acquired a new position in shares of JPMorgan Chase & Co. (NYSE:JPM - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 3,441 shares of the financial services provider's stock, valued at approximately $825,000.

A number of other large investors have also recently bought and sold shares of JPM. Geode Capital Management LLC grew its holdings in JPMorgan Chase & Co. by 0.9% in the 3rd quarter. Geode Capital Management LLC now owns 58,344,186 shares of the financial services provider's stock worth $12,258,346,000 after buying an additional 505,830 shares in the last quarter. Fisher Asset Management LLC increased its holdings in shares of JPMorgan Chase & Co. by 31.7% during the third quarter. Fisher Asset Management LLC now owns 16,784,272 shares of the financial services provider's stock valued at $3,539,132,000 after purchasing an additional 4,043,841 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its stake in shares of JPMorgan Chase & Co. by 2.0% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 15,084,919 shares of the financial services provider's stock valued at $3,180,806,000 after purchasing an additional 302,592 shares in the last quarter. Franklin Resources Inc. lifted its holdings in JPMorgan Chase & Co. by 7.2% in the third quarter. Franklin Resources Inc. now owns 15,073,193 shares of the financial services provider's stock worth $3,338,955,000 after purchasing an additional 1,016,289 shares during the period. Finally, Sanders Capital LLC boosted its holdings in shares of JPMorgan Chase & Co. by 0.6% in the third quarter. Sanders Capital LLC now owns 8,194,767 shares of the financial services provider's stock valued at $1,727,949,000 after acquiring an additional 49,695 shares in the last quarter. Institutional investors own 71.55% of the company's stock.

Remove Ads

JPMorgan Chase & Co. Stock Performance

JPM traded up $2.10 during trading on Wednesday, hitting $231.24. The stock had a trading volume of 8,035,395 shares, compared to its average volume of 8,793,080. The firm has a market cap of $646.57 billion, a PE ratio of 11.71, a P/E/G ratio of 2.83 and a beta of 1.10. The company has a current ratio of 0.88, a quick ratio of 0.89 and a debt-to-equity ratio of 1.24. JPMorgan Chase & Co. has a 12 month low of $179.20 and a 12 month high of $280.25. The company has a 50 day simple moving average of $259.05 and a 200-day simple moving average of $238.78.

JPMorgan Chase & Co. (NYSE:JPM - Get Free Report) last posted its quarterly earnings data on Wednesday, January 15th. The financial services provider reported $4.81 EPS for the quarter, topping analysts' consensus estimates of $4.03 by $0.78. The business had revenue of $42.77 billion for the quarter, compared to analyst estimates of $41.90 billion. JPMorgan Chase & Co. had a return on equity of 16.99% and a net margin of 20.96%. The firm's revenue for the quarter was up 10.9% on a year-over-year basis. During the same period in the previous year, the company posted $3.04 earnings per share. Analysts expect that JPMorgan Chase & Co. will post 18.1 EPS for the current year.

Wall Street Analyst Weigh In

Several equities research analysts have commented on JPM shares. Wolfe Research upgraded shares of JPMorgan Chase & Co. from a "peer perform" rating to an "outperform" rating and set a $269.00 price target on the stock in a research report on Friday, January 3rd. UBS Group increased their price objective on JPMorgan Chase & Co. from $276.00 to $287.00 and gave the stock a "buy" rating in a research note on Thursday, January 16th. Piper Sandler increased their price objective on JPMorgan Chase & Co. from $240.00 to $275.00 and gave the stock an "overweight" rating in a report on Tuesday, December 3rd. Barclays raised their price target on JPMorgan Chase & Co. from $304.00 to $330.00 and gave the stock an "overweight" rating in a research note on Thursday, January 16th. Finally, Wells Fargo & Company boosted their price target on JPMorgan Chase & Co. from $240.00 to $270.00 and gave the company an "overweight" rating in a research note on Friday, November 15th. Ten investment analysts have rated the stock with a hold rating and ten have issued a buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average target price of $252.89.

Insider Transactions at JPMorgan Chase & Co.

In other news, General Counsel Stacey Friedman sold 3,303 shares of the company's stock in a transaction dated Thursday, January 16th. The shares were sold at an average price of $253.94, for a total transaction of $838,763.82. Following the completion of the transaction, the general counsel now owns 47,620 shares of the company's stock, valued at approximately $12,092,622.80. This represents a 6.49 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Robin Leopold sold 1,250 shares of JPMorgan Chase & Co. stock in a transaction dated Thursday, February 20th. The stock was sold at an average price of $270.09, for a total value of $337,612.50. Following the sale, the insider now directly owns 50,377 shares in the company, valued at approximately $13,606,323.93. This trade represents a 2.42 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 46,326 shares of company stock worth $12,448,445 over the last three months. 0.79% of the stock is currently owned by insiders.

JPMorgan Chase & Co. Company Profile

JPMorgan Chase & Co is a financial holding company, which engages in the provision of financial and investment banking services. The firm offers a range of investment banking products and services in all capital markets, including advising on corporate strategy and structure, capital raising in equity and debt markets, risk management, market making in cash securities and derivative instruments, and brokerage and research.